Exploring C-peptide loss in type 1 diabetes using growth curve analysis.

Exploring C-peptide loss in type 1 diabetes using growth curve analysis.

<h4>Objectives</h4>C-peptide (CP) loss in type 1 diabetes (T1D) is highly variable, and factors influencing it are poorly understood. We modelled CP values in T1D patients from diagnosis for up to 6 years, treating the serial data as growth curves plotted against time since diagnosis. Th...

Bibliografski detalji
Glavni autori:	Rachel E J Besser, Johnny Ludvigsson, Peter C Hindmarsh, Tim J Cole
Format:	Članak
Jezik:	English
Izdano:	Public Library of Science (PLoS) 2018-01-01
Serija:	PLoS ONE
Online pristup:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199635&type=printable

Slični predmeti

Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis
od: Johnny Ludvigsson, i dr.
Izdano: (2022-11-01)

Physical Activity, Blood Glucose and C-Peptide in Healthy School-Children, a Longitudinal Study.
od: Karina Huus, i dr.
Izdano: (2016-01-01)

Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study
od: Johnny Ludvigsson, i dr.
Izdano: (2024-05-01)

Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes
od: Hugo Barcenilla, i dr.
Izdano: (2019-05-01)

Increase of Neutrophil Extracellular Traps, Mitochondrial DNA and Nuclear DNA in Newly Diagnosed Type 1 Diabetes Children but Not in High-Risk Children
od: Camilla Skoglund, i dr.
Izdano: (2021-06-01)

Assessment of height growth in Indian children using growth centiles and growth curves
od: Sandra Aravind Areekal, i dr.
Izdano: (2022-08-01)

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype
od: Sara Puente-Marin, i dr.
Izdano: (2023-02-01)

Insulin-Like Growth Factor-1 at Diagnosis and during Subsequent Years in Adolescents with Type 1 Diabetes
od: Simona I. Chisalita, i dr.
Izdano: (2018-01-01)

The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
od: Massoud, A, i dr.
Izdano: (1996)

Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes
od: Hugo Barcenilla, i dr.
Izdano: (2022-01-01)

No association between incidence of type 1 diabetes and rotavirus vaccination in Swedish children
od: Amanda Rangert, i dr.
Izdano: (2023-08-01)

Type 1 diabetes in low and middle-income countries - Tanzania a streak of hope
od: Johnny Ludvigsson, i dr.
Izdano: (2023-03-01)

Association between area under the C‐peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients
od: Cong Zhang, i dr.
Izdano: (2024-03-01)

C-Peptide as a Therapy for Type 1 Diabetes Mellitus
od: Rachel L. Washburn, i dr.
Izdano: (2021-03-01)

Islet amyloid in recent-onset type 1 diabetes—the DiViD study
od: Gunilla T. Westermark, i dr.
Izdano: (2017-07-01)

Infections and antibiotic use in early childhood have limited importance in developing manifest type 1 diabetes – The ABIS cohort study
od: Malin Bélteky, i dr.
Izdano: (2025-02-01)

Computing local p-adic height pairings on hyperelliptic curves
od: Balakrishnan, J, i dr.
Izdano: (2010)

Predictive biomarkers of rapidly developing insulin deficiency in children with type 1 diabetes
od: Johnny Ludvigsson, i dr.
Izdano: (2024-02-01)

Opiate peptides control growth hormone through a cholinergic mechanism in man.
od: Delitala, G, i dr.
Izdano: (1983)

Exploring the Role of Vitamin D2, Parathyroid Hormone, and C-Peptides as Biomarkers in Diabetic Neuropathy Development
od: Ban Mahmood Shaker Al-Joda, i dr.
Izdano: (2024-07-01)

Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.
od: Linda Åkerman, i dr.
Izdano: (2018-01-01)

Growth hormone predicts baseline bone density but not bone loss in elderly women
od: Dennison, E, i dr.
Izdano: (2000)

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes
od: Beatriz Tavira, i dr.
Izdano: (2018-01-01)

Quadratic Chabauty: p-adic height pairings and integral points on hyperelliptic curves
od: Balakrishnan, J, i dr.
Izdano: (2013)

Preventing muscle wasting: pro‐insulin C‐peptide prevents loss in muscle mass in streptozotocin‐diabetic rats
od: Samantha Maurotti, i dr.
Izdano: (2023-04-01)

Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
od: Giesje Nefs, i dr.
Izdano: (2021-03-01)

The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT
od: Charlotte K Boughton, i dr.
Izdano: (2024-05-01)

Transdermal blood sampling for C-peptide is a minimally invasive, reliable alternative to venous sampling in children and adults with type 1 diabetes
od: Besser, REJ, i dr.
Izdano: (2023)

Low maternal education increases the risk of Type 1 Diabetes, but not other autoimmune diseases: a mediating role of childhood BMI and exposure to serious life events
od: Pär Andersson White, i dr.
Izdano: (2023-04-01)

C-peptide persistence in type 1 diabetes: ‘not drowning, but waving’?
od: R. David Leslie, i dr.
Izdano: (2019-09-01)

Curves of ground proximity loss for dipole antennas /
od: 253585 Vogler, L. E., i dr.
Izdano: (1963)

Bidirectional association between inflammatory bowel disease and type 1 diabetes: a nationwide matched cohort and case-control studyResearch in context
od: Jiangwei Sun, i dr.
Izdano: (2024-11-01)

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes
od: Paul M. McKeigue, i dr.
Izdano: (2019-08-01)

Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study
od: Erik Kindgren, i dr.
Izdano: (2021-09-01)

Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D
od: Anneli Björklund, i dr.
Izdano: (2022-07-01)

Prediction of Diabetes Using Serum C-Peptide
od: Hye Seung Jung
Izdano: (2016-06-01)

C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity
od: Regina Esze, i dr.
Izdano: (2024-08-01)

LOSS OF NORMAL SIGMOID, BETA-CELL DOSE-RESPONSE CURVE TO GLUCOSE IN NON-INSULIN-DEPENDENT DIABETES
od: Hosker, J, i dr.
Izdano: (1984)

The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.
od: Rudenski, A, i dr.
Izdano: (1988)

Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.
od: Mullis, P, i dr.
Izdano: (1992)